IntelGenx Technologies Corp. (IGXT) Financial Statements (2024 and earlier)

Company Profile

Business Address 6420 ABRAMS
SAINT LAURENT, QC H4S 1Y2
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,5279,9491,0385804,1804,904
Cash and cash equivalents1,2103,945   1,591
Short-term investments1,3176,0041,0385804,1803,313
Receivables709680260381815623
Inventory, net of allowances, customer advances and progress billings6262244382375 
Inventory6262244382375 
Prepaid expense137105162170462203
Contract with customer, asset, after allowance for credit loss   354  
Deposits current assets194205407   
Other undisclosed current assets1594361,8401,7077,231314
Total current assets:3,78811,4374,3053,22013,0636,044
Noncurrent Assets
Operating lease, right-of-use asset7321,003710683
Property, plant and equipment4,4255,2135,8516,3656,2486,346
Deposits noncurrent assets245252252752707757
Total noncurrent assets:5,4026,4686,8137,8006,9557,103
TOTAL ASSETS:9,19017,90511,11811,02020,01813,147
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,1022,2991,9891,9412,0301,305
Other undisclosed accounts payable and accrued liabilities2,1022,2991,9891,9412,0301,305
Deferred revenue 189166 
Debt364,2837278646921
Other undisclosed current liabilities2362491,4865,642 771
Total current liabilities:2,3747,0204,3688,4472,7222,077
Noncurrent Liabilities
Long-term debt and lease obligation5,5423,2267371,0251,18952
Long-term debt, excluding current maturities5,5002,5001714701,1402
Capital lease obligations4950
Finance lease, liability428484 
Liabilities, other than long-term debt42579    
Deferred income tax liabilities  79  
Operating lease, liability425642482555
Other undisclosed noncurrent liabilities4,2723,7096,9661,2556,1207,189
Total noncurrent liabilities:10,2397,0147,7032,2807,3097,241
Total liabilities:12,61314,03412,07110,72710,0319,318
Equity
Equity, attributable to parent(3,423)3,871(953)2939,9873,829
Common stock111111
Additional paid in capital67,34063,10448,45342,63542,04825,253
Accumulated other comprehensive loss(2,234)(1,371)(856)(836)(1,166)(637)
Accumulated deficit(68,530)(57,863)(48,551)(41,507)(30,896)(20,788)
Total equity:(3,423)3,871(953)2939,9873,829
TOTAL LIABILITIES AND EQUITY:9,19017,90511,11811,02020,01813,147

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues9501,5351,5447421,8245,195
Revenue, net5,195
Cost of revenue(1,858)(2,256)(96)(96)(63)(373)
Cost of goods and services sold(1,858)(2,256)   (373)
Financing interest expense   (96)(96)(63)
Gross profit:(908)(721)1,4486461,7614,822
Operating expenses(10,363)(9,517)(7,808)(10,292)(10,822)(7,688)
Other undisclosed operating income1,8582,256969663373
Operating loss:(9,413)(7,982)(6,264)(9,550)(8,998)(2,493)
Nonoperating expense(1,277)(1,336)(780)(1,110)(1,110)(558)
Investment income, nonoperating4152422971111
Interest and debt expense(73)(74)(74)(952)(1,237)417
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   749521,237(417)
Loss from continuing operations before equity method investments, income taxes:(10,763)(9,392)(7,044)(10,660)(10,108)(3,051)
Other undisclosed income (loss) from continuing operations before income taxes7374    
Loss from continuing operations before income taxes:(10,690)(9,318)(7,044)(10,660)(10,108)(3,051)
Income tax benefit  6    
Loss from continuing operations:(10,690)(9,312)(7,044)(10,660)(10,108)(3,051)
Loss before gain (loss) on sale of properties:(9,312)(7,044)(10,660)(10,108)(3,051)
Net loss:(10,690)(9,312)(7,044)(10,660)(10,108)(3,051)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, basic:(10,690)(9,312)(7,044)(10,660)(10,108)(3,051)
Interest on convertible debt171549452457607 
Net loss available to common stockholders, diluted:(10,519)(8,763)(6,592)(10,203)(9,501)(3,051)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(10,690)(9,312)(7,044)(10,660)(10,108)(3,051)
Comprehensive loss:(10,690)(9,312)(7,044)(10,660)(10,108)(3,051)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(863)(515)(20)330(529)382
Comprehensive loss, net of tax, attributable to parent:(11,553)(9,827)(7,064)(10,330)(10,637)(2,669)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: